One of the effects of altered VEGF levels in BPD and ROP is the impact on activation of the type 2 VEGF receptor (vascular endothelial growth factor receptor 2, VEGFR2) that stimulates endothelial nitric oxide synthase (eNOS) production in endothelial cells (33). This evidence concerns the gene KDR and bronchopulmonary dysplasia.